Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2002-09-06
2009-06-02
Jiang, Shaojia Anna (Department: 1623)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S123000, C514S054000, C514S056000
Reexamination Certificate
active
07541445
ABSTRACT:
Preparation of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids.
REFERENCES:
patent: 4401662 (1983-08-01), Lormeau et al.
patent: 4496550 (1985-01-01), Lindahl et al.
patent: 4607025 (1986-08-01), Petitou et al.
patent: 4818816 (1989-04-01), Petitou et al.
patent: 5939588 (1999-08-01), Soloshonok et al.
patent: 6846917 (2005-01-01), Seeberger et al.
patent: 2003/0013862 (2003-01-01), Seeberger et al.
patent: 2005/0187381 (2005-08-01), Seeberger et al.
patent: 10397/83 (1983-08-01), None
patent: 42637/85 (1985-11-01), None
patent: 0082793 (1983-06-01), None
patent: 0 084 999 (1983-08-01), None
patent: 0 084 999 (1983-08-01), None
patent: 0333243 (1989-09-01), None
patent: 2 531 436 (1984-02-01), None
patent: 2531436 (1984-02-01), None
patent: 63-218691 (1988-09-01), None
patent: 63-218691 (1988-09-01), None
patent: 3-237101 (1991-10-01), None
patent: 3-237101 (1991-10-01), None
patent: 10-182576 (1998-07-01), None
patent: WO 82/03863 (1982-11-01), None
patent: WO 95/03316 (1995-02-01), None
Greene et al., “Protective groups in Organic Synthesis, Second edition” Published by John Wiley and Sons, (1999) pp. 46-52, 88-92, and 413-420.
Greene et al., Protective Groups in Organis Synthesis, published 1999 by John Wiley and Sons, pp. 42-46, 53-54, 83-84, 100-103, 413-452.
Ichikawa et al., “Synthesis of a Heparin Pentasaccharide Fragment with a High Affinity for Antithrombin III Employing Cellobiose as a key Starting Material” Tetrahedron Letters (1986) vol. 27, No. 5, pp. 611-614.
Basten, J. et al. (1992). “Biologically Active Heparin-like Fragments with a “Non-Glycosamino” Glycan Structure. Part 2: A Tetra-O-Methylated Pentasaccharide with High Affinity for Antithrombin III,”Bioorg. Med. Chem. Lett. 2(9):901-904.
Beetz, T. et al. (1986). “Synthesis of an Antithrombin Binding Heparin-Like Pentasaccharide Lacking 6-O Sulphate at its Reducing End,”Tetrahedron Letters27(48):5889-5892.
Duchaussoy, P. et al. (1991). “The First Total Synthesis of the Antithrombin III Binding Site of Porcine Mucosa Heparin,”Bioorg. Med. Chem. Lett. 1(2):99-102.
Ichikawa, Y. et al. (1988). “Synthesis of Methyl Glycoside Derivatives of Tri- and Penta-Saccharides Related to the Antithrombin III-Binding Sequence of Heparin, Employing Cellobiose as a Key Starting-Material,”Carb. Res. 172(1):37-64.
International Search Report mailed Jan. 13, 2003 for PCT Application No. PCT/AU02/01228, 6 pages.
Jaurand, G. et al. (Sep. 1992). “Biologically Active Heparin-like Fragments with a “Non-Glycosamino” Glycan Structure. Part 1: A Pentasaccharide Containing a 3-O-Methyl Iduronic Acid Unit,”Bioorg. Med. Chem. Lett. 2(9):897-900.
Lei, P-S. et al. (1998). “Synthesis of a 3-Deoxy-L-iduronic Acid Containing Heparin Pentasaccharide to Probe the Conformation of the Antithrombin III Binding Sequence,”Biororg. Med. Chem. 6:1337-1346.
Love, K.R. et al. (2001). “Linear Synthesis of a Protected H-Type II Pentasaccharide Using Glycosyl Phosphate Building Blocks,”J. Org. Chem. 66:8165-8176.
Lucas H. et al. (1990). “Syntheses of Heparin-like Pentamers Containing “Opened” Uronic Acid Moieties,”Tetrahedron46(24):8207-8228.
Orgueira, H.A. et al. (2003). “Modular Synthesis of Heparin Oligosaccharides,”Chemistry Eur. J. 9(1):140-169.
Petitou, M. (1984). “Synthetic Heparin Fragments: New and Efficient Tools for the Study of Heparin and its Interactions,”Nouv. Rev. Fr. Hematol. 26:221-226.
Petitou, M. et al. (1987). “Synthesis of Heparin Fragments: A Methyl α-Pentaoside with High Affinity for Antithrombin III,”Carbohydrate Research167:67-75.
Petitou, M. et al. (1988). “Binding of Heparin to Antithrombin III: A Chemical Proof of the Critical Role Played by a 3-Sulfated 2-Amino-2-Deoxy-D-Glucose Residue,”Carbohydrate Res. 179:163-172.
Petitou, M. et al. (1991). “A New, Highly Potent, Heparin-like Pentasaccharide Fragment Containing a Glucose Residue Instead of a Glucosamine,”Bioorg. Med. Chem. Lett. 1(2):95-98.
Petitou, M. et al. (1992). “Chemical Synthesis of Heparin Fragments and Analogues,”Fortschr. Chem. Org. Naturst. 60:143-210.
STN File CA Abstract Accession No. 119:181118 for Jaurand, G. et al. (1992). “Biologically Active Heparin-like Fragments with a ‘Non-Glycosamino’ Glycan Structure: Part 1: A Pentasaccharide Containing a 3-O-Methyl Iduronic Acid Unit,”Bioorg. Med. Chem. Lett. 2(9):897-900.
Tamura, J. et al. (1996). “Synthetic Studies of Glycosyl Serines in the Carbohydrate-Protein Region of Protoglycans,”Liebigs Annalen, pp. 1239-1257.
van Aelst, S.F. et al. (Nov. 1987). “Synthesis of an Analogue of the Antithrombin Binding Region of Heparin Containing α-L-Idopyranose,”Recl. Trav. Chim. Pays-Bas106(11):593-595.
van Boeckel, C.A.A. (1997). “Synthetic Heparin-like Antithrombotics,”Pure&Appl. Chem. 69(3):389-394.
van Boeckel, C.A.A. et al. (1985). “Synthesis of a Pentasaccharide Corresponding to the Antithrombin III Binding Fragment of Heparin,”J. Carbohydrate Chemistry4(3):293-321.
van Boeckel, C.A.A. et al. (1988). “Synthesis of a Potent Antithrombin Activating Pentasaccharide: A New Heparin-Like Fragment Containing Two 3-O-Sulphated Glucosamines,”Tetrahedron Letters29(7):803-806.
Vos, J.N. et al. (1991). “Synthesis of a 6-O-Phosphorylated Analogue of the Antihrombin III Binding Sequence of Heparin: Replacement of One Essential Sulphate Group by a Phosphate Group Nullifies the Biological Activity,”Bioorg. Med. Chem. Lett. 1(3):143-146.
Wessel, H.P. et al. (1989). “140. Synthesis of aN-Acetylated Heparin Pentasaccharide and its Anticoagulant Activity in Comparison with the Heparin Pentasaccharide with High Anti-Factor-Xa Activity,”Helv. Chim. Acta72:1268-1277.
STN File CA Abstract Accession No. 104:130179 & Ichikawa, Y. et al., “Synthetic studies on mucopolysaccharides. Part III. Synthesis, from cellobiose of a trisaccharide closely related to the GlcNAc—GlcA—GlcN segment of the antithrombin-binding sequence of herapin”, Carbohydrate Research, 1985, pp. 272-282, vol. 141, No. 2.
STN File CA Abstract Accession No. 136:70031 & Love K R et al., “Linear synthesis of a protected H-type II pentasaccharide using glycosyl phosphate building blocks”, Journal of Organic Chemistry, 2001, pp. 8165-8176, vol. 66, No. 24.
Choay, J. et al. (1981). “Structural Studies on a Biologically Active Hexasaccharide Obtained from Heparin,”Annals of New York Academy of Sciencespp. 644-648.
Choay, J. et al. (Oct. 31, 1983). “Structure-Activity Relationship in Heparin: A Synthetic Pentasaccharide with High Affinity for Antithrombin III and Eliciting High Anti-Factor Xa Activity,”Biochemical and Biophysical Research Communications116(2):492-499.
Lindahl, U. et al. (Nov. 1980). “Evidence for a 3-O-Sulfated D-Glucosamine Residue in the Antithrombin-Binding Sequence of Heparin,”Biochemistry77(11):6551-6555.
Riesenfeld, J. et al. (Mar. 10, 1981). “The Antithrombin-Binding Sequence of Heparin,”The Journal of Biological Chemistry256(5):2389-2394.
Sinay, P. et al. (1984). “Total Synthesis of a Heparin Pentasaccharide Fragment Having High Affinity for Antithrombin III,”Carbohydrate Research132:C5-C9.
Petitou, M. et al. (1986). “Synthesis of Heparin Fragments. A Chemical Synthesis of the Pentasaccharide0-(2-Deoxy-2-Sulfamido-6-O-Sulfo-α-D-Glucopyranosyl)-(1→4)-O-(β-D-Glucopyranosyluronic Acid)-(1→4)-O-(2-Deoxy-2-Sulfamido-3,6-Di-O-Sulfo-α-D-Glucopyranosyl)-(1→4)-O-(2-O-Sulfo-α-L-Idopyranosyluronic Acid)-(1→4)-2-Deoxy-2-Sulfamido-6-O-D-Glucopyranose Decasodium Salt, A Heparin Fragment Having High A
Drinnan Nicholas B.
Ramsdale Tracie E.
Seifert Joachim
Singh Latika
West Michael L.
Alchemia Limited
Jiang Shaojia Anna
Morrison & Foerster / LLP
Olson Eric S
LandOfFree
Synthetic heparin pentasaccharides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic heparin pentasaccharides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic heparin pentasaccharides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4123391